ResearcherJiangsu Province HospitalActive in the last 2 years
Guangfu Wang
Matched on ORCID iD 0000-0003-4065-1054; OpenAlex author ID A5101709198. Sources: OpenAlex.
Their work
- Papers
- 8
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 21
2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 2 papers
Papers 8
- LIM domain only 7: a novel driver of immune evasion through regulatory T cell differentiation and chemotaxis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41418-024-01358-7↗
- USP19 potentiates autophagic cell death via inhibiting mTOR pathway through deubiquitinating NEK9 in pancreatic cancer. Co-author DOI 10.1038/s41418-024-01426-y↗
- High pyroptosis activity in pancreatic adenocarcinoma: poor prognosis and oxaliplatin resistance. Co-author DOI 10.1007/s10495-023-01901-w↗
- Cancer-testis gene STK31 is regulated by methylation and promotes the development of pancreatic cancer. Co-author DOI 10.1002/cam4.5472↗
- Prognostic impact of the ratio of preoperative CA19-9 to liver enzyme levels in pancreatic cancer patients with jaundice (predictability of combined CA19-9/AST… Co-author DOI 10.1016/j.pan.2021.05.300↗
- Opposite Roles of Tumor Cell Proliferation and Immune Cell Infiltration in Postoperative Liver Metastasis of PDAC. Co-author DOI 10.3389/fcell.2021.714718↗
- Higher miR-543 levels correlate with lower STK31 expression and longer pancreatic cancer survival. Co-author DOI 10.1002/cam4.3559↗
- Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case-control study. Co-author DOI 10.1007/s00423-019-01766-1↗
Closest collaborators
The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zipeng Lu · 6 shared papers, 2021–2025 · strength 1.10
- Paper USP19 potentiates autophagic cell death via inhibiting mTOR pathway through deubiquitinating NEK9 in pancreatic cancer. DOI 10.1038/s41418-024-01426-y↗
- Paper High pyroptosis activity in pancreatic adenocarcinoma: poor prognosis and oxaliplatin resistance. DOI 10.1007/s10495-023-01901-w↗
- Paper LIM domain only 7: a novel driver of immune evasion through regulatory T cell differentiation and chemotaxis in pancrea… DOI 10.1038/s41418-024-01358-7↗
- Yi Miao · 7 shared papers, 2019–2025 · strength 1.10
- Paper USP19 potentiates autophagic cell death via inhibiting mTOR pathway through deubiquitinating NEK9 in pancreatic cancer. DOI 10.1038/s41418-024-01426-y↗
- Paper LIM domain only 7: a novel driver of immune evasion through regulatory T cell differentiation and chemotaxis in pancrea… DOI 10.1038/s41418-024-01358-7↗
- Paper Cancer-testis gene STK31 is regulated by methylation and promotes the development of pancreatic cancer. DOI 10.1002/cam4.5472↗
- Lingdi Yin · 5 shared papers, 2019–2025 · strength 0.86
- Paper USP19 potentiates autophagic cell death via inhibiting mTOR pathway through deubiquitinating NEK9 in pancreatic cancer. DOI 10.1038/s41418-024-01426-y↗
- Paper High pyroptosis activity in pancreatic adenocarcinoma: poor prognosis and oxaliplatin resistance. DOI 10.1007/s10495-023-01901-w↗
- Paper LIM domain only 7: a novel driver of immune evasion through regulatory T cell differentiation and chemotaxis in pancrea… DOI 10.1038/s41418-024-01358-7↗
- Shangnan Dai · 4 shared papers, 2021–2025 · strength 0.78
- Paper USP19 potentiates autophagic cell death via inhibiting mTOR pathway through deubiquitinating NEK9 in pancreatic cancer. DOI 10.1038/s41418-024-01426-y↗
- Paper High pyroptosis activity in pancreatic adenocarcinoma: poor prognosis and oxaliplatin resistance. DOI 10.1007/s10495-023-01901-w↗
- Paper LIM domain only 7: a novel driver of immune evasion through regulatory T cell differentiation and chemotaxis in pancrea… DOI 10.1038/s41418-024-01358-7↗
- Kuirong Jiang · 5 shared papers, 2019–2025 · strength 0.77
- Paper USP19 potentiates autophagic cell death via inhibiting mTOR pathway through deubiquitinating NEK9 in pancreatic cancer. DOI 10.1038/s41418-024-01426-y↗
- Paper LIM domain only 7: a novel driver of immune evasion through regulatory T cell differentiation and chemotaxis in pancrea… DOI 10.1038/s41418-024-01358-7↗
- Paper Prognostic impact of the ratio of preoperative CA19-9 to liver enzyme levels in pancreatic cancer patients with jaundic… DOI 10.1016/j.pan.2021.05.300↗
- Hao Gao Gao · 4 shared papers, 2019–2023 · strength 0.54
- Paper Cancer-testis gene STK31 is regulated by methylation and promotes the development of pancreatic cancer. DOI 10.1002/cam4.5472↗
- Paper Opposite Roles of Tumor Cell Proliferation and Immune Cell Infiltration in Postoperative Liver Metastasis of PDAC. DOI 10.3389/fcell.2021.714718↗
- Paper Higher miR-543 levels correlate with lower STK31 expression and longer pancreatic cancer survival. DOI 10.1002/cam4.3559↗
- Kai Zhang · 3 shared papers, 2020–2025 · strength 0.54
- Paper USP19 potentiates autophagic cell death via inhibiting mTOR pathway through deubiquitinating NEK9 in pancreatic cancer. DOI 10.1038/s41418-024-01426-y↗
- Paper Cancer-testis gene STK31 is regulated by methylation and promotes the development of pancreatic cancer. DOI 10.1002/cam4.5472↗
- Paper Higher miR-543 levels correlate with lower STK31 expression and longer pancreatic cancer survival. DOI 10.1002/cam4.3559↗
- Junli Wu · 3 shared papers, 2019–2025 · strength 0.42
- Paper LIM domain only 7: a novel driver of immune evasion through regulatory T cell differentiation and chemotaxis in pancrea… DOI 10.1038/s41418-024-01358-7↗
- Paper Higher miR-543 levels correlate with lower STK31 expression and longer pancreatic cancer survival. DOI 10.1002/cam4.3559↗
- Paper Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case-control study. DOI 10.1007/s00423-019-01766-1↗
- Kuirong Jiang · 2 shared papers, 2023–2024 · strength 0.41
- Baobao Cai · 2 shared papers, 2021–2023 · strength 0.33
- Yunpeng Peng · 2 shared papers, 2019–2025 · strength 0.29
- Paper LIM domain only 7: a novel driver of immune evasion through regulatory T cell differentiation and chemotaxis in pancrea… DOI 10.1038/s41418-024-01358-7↗
- Paper Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case-control study. DOI 10.1007/s00423-019-01766-1↗
- Jishu Wei · 2 shared papers, 2019–2025 · strength 0.29
- Paper LIM domain only 7: a novel driver of immune evasion through regulatory T cell differentiation and chemotaxis in pancrea… DOI 10.1038/s41418-024-01358-7↗
- Paper Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case-control study. DOI 10.1007/s00423-019-01766-1↗
- Xumin Huang · 2 shared papers, 2021 · strength 0.27
- Paper Prognostic impact of the ratio of preoperative CA19-9 to liver enzyme levels in pancreatic cancer patients with jaundic… DOI 10.1016/j.pan.2021.05.300↗
- Paper Opposite Roles of Tumor Cell Proliferation and Immune Cell Infiltration in Postoperative Liver Metastasis of PDAC. DOI 10.3389/fcell.2021.714718↗
- Kai Zhang · 2 shared papers, 2019–2021 · strength 0.22
- Paper Prognostic impact of the ratio of preoperative CA19-9 to liver enzyme levels in pancreatic cancer patients with jaundic… DOI 10.1016/j.pan.2021.05.300↗
- Paper Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case-control study. DOI 10.1007/s00423-019-01766-1↗
- Yi Miao · 1 shared paper, 2024 · strength 0.22
- Qiuyang Chen · 1 shared paper, 2025 · strength 0.21
- Min Tu · 1 shared paper, 2025 · strength 0.21
- Pengfei Wu · 1 shared paper, 2021 · strength 0.13
- Weizhong Yuan · 1 shared paper, 2020 · strength 0.13
- Nan Lyu · 1 shared paper, 2019 · strength 0.08
- Wentao Gao · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.